Pathos AI has partnered with Bristol Myers Squibb and Tempus AI to use agentic AI and clinical data to speed up neuroscience drug development, with an initial focus on Alzheimer’s disease.
The Ghost in the Shell franchise is getting a new anime project, with Science SARU returning as the animation studio. Announced on October 23, 2026, the production is based on Masamune Shirow’s cyberp ...
Bose and Skullcandy differ in sound profiles, noise cancellation, design, and pricing. Following Bose's acquisition of Skullcandy on October 21, 2026, both brands retain distinct identities while shar ...
.png){kind=logo}
